Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.

Annals of surgery - 1 Sept 2011

Garcia-Aguilar Julio, Chen Zhenbin, Smith David D, Li Wenyan, Madoff Robert D, Cataldo Peter, Marcet Jorge, Pastor Carlos

Abstract excerpt

OBJECTIVE: To identify a biomarker profile associated with tumor response to chemoradiation (CRT) in locally advanced rectal cancer. BACKGROUND: Rectal cancer response to neoadjuvant CRT is variable. Whereas some patients have a minimal response, others achieve a pathologic complete response (pCR) and have no viable cancer cells in their surgical specimens. Identifying biomarkers of response will help select...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to Cyclin D1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucovorin

Share to Neoadjuvant Therapy

Share to Organoplatinum Compounds

Share to Radiotherapy, Adjuvant

Share to Radiotherapy Dosage

Share to Rectal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 21865946
DOI: 10.1097/SLA.0b013e31822b8cfa
PMCID: PMC3202983

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.PMID 21865946Read ↗

Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancerSemantic proximity Read ↗

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapySemantic proximity Read ↗

The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.Semantic proximity Read ↗

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Semantic proximity Read ↗

Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.Semantic proximity Read ↗

Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer.Semantic proximity Read ↗

KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.Semantic proximity Read ↗

A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer.Semantic proximity Read ↗

Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancerSemantic proximity Read ↗

Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.Semantic proximity Read ↗

Gene expression profile is associated with chemoradiation resistance in rectal cancerSemantic proximity Read ↗

Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.